Peptidic dual GLP-1 / glucagon receptor agonists derived from exendin-4

A receptor and selected technology, applied in the direction of glucagon, peptide/protein components, hormone peptides, etc., can solve the chemical instability of exendin-4 and other problems

Active Publication Date: 2017-02-15
SANOFI SA
View PDF35 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] However, because of the oxidation of methionine at position 14 (Hargrove DM et al., Regul. Pept., 141:113-9, 2007

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Peptidic dual GLP-1 / glucagon receptor agonists derived from exendin-4
  • Peptidic dual GLP-1 / glucagon receptor agonists derived from exendin-4
  • Peptidic dual GLP-1 / glucagon receptor agonists derived from exendin-4

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0420] Example 1:

[0421] Synthesize SEQ ID NO: 8

[0422] The manual synthesis method as described in the method was performed on dry Rink amide MBHA resin (0.66 mmol / g). The Fmoc-synthesis strategy is implemented with DIC / HOBt-activation. Fmoc-Lys(ivDde)-OH was used in position 14 and Boc-His(Boc)-OH was used in position 1. According to a modified literature method (S.R. Chhabra et al., Tetrahedron Lett. 39, (1998), 1603) 4% hydrazine hydrate in DMF is used to cleave the ivDde- group from the peptide on the resin. The peptide was excised from the resin with King's cocktail (D.S. King, C.G. Fields, G.B. Fields, Int. J. Peptide Protein Res. 36, 1990, 255-266). The crude product was purified via preparative HPLC using an acetonitrile / water gradient (0.1% TFA in both buffers). The purified peptide was analyzed by LCMS (Method C).

[0423] The deconvolution of the mass signal with a retention time of 12.66 minutes under the peak revealed that the peptide mass is 4557.6, which is c...

Example Embodiment

[0424] Example 2:

[0425] Synthesize SEQ ID NO: 11

[0426] The manual synthesis method as described in the method was performed on dry Rink amide MBHA resin (0.66 mmol / g). The Fmoc-synthesis strategy was implemented with DIC / HOBt-activation. Use Fmoc-Lys(ivDde)-OH in position 14 and Boc-His(Boc)-OH in position 1. According to a modified literature method (S.R. Chhabra et al., Tetrahedron Lett. 39, (1998), 1603) 4% hydrazine hydrate in DMF is used to cleave the ivDde- group from the peptide on the resin. The peptide was excised from the resin with King's cocktail (D.S. King, C.G. Fields, G.B. Fields, Int. J. Peptide Protein Res. 36, 1990, 255-266). The crude product was purified via preparative HPLC using an acetonitrile / water gradient (0.1% TFA in both buffers). The purified peptide was analyzed by LCMS (Method D).

[0427] The deconvolution of the mass signal with a retention time of 14.40 minutes under the peak revealed that the peptide mass is 4673.6, which is consistent wi...

Example Embodiment

[0435] Example 3: Stability and solubility

[0436] The solubility and stability of the peptide compound were evaluated as described in the method. The results are given in Table 5.

[0437] Table 5: Stability and solubility

[0438]

[0439]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Peptidic dual GLP-1 / Glucagon Receptor Agonists derived from Exendin-4 The present invention relates to dual GLP-1 / glucagon receptor agonists or optionally trigonal GLP-1 / glucagon / GIP receptor agonists and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as for reduction of excess food intake.

Description

[0001] field of invention [0002] The present invention relates to exendin-4 (exendin-4) peptide analogs, which activate glucagon-like peptide-1 (GLP-1) and glucagon (GCG) receptors and optionally glucose- Dependent insulinotropic polypeptide (GIP) receptors, and their medical uses, for example in the treatment of disorders of the metabolic syndrome (including diabetes and obesity) and in reducing excess food intake. [0003] Background of the invention [0004] Exendin-4 is a 39-amino acid peptide produced by the salivary glands of the monster monster (Heloderma suspectum) (Eng J. et al., J. Biol. Chem., 1992, 267, 7402- 05). Exendin-4 is an activator of the glucagon-like peptide-1 (GLP-1) receptor, but it shows only very low activation of the GIP receptor and does not activate the glucagon receptor (see Table 1). [0005] Table 1: Potency (expressed in pM) of increasing concentrations of exendin-4 on GLP-1, GIP and glucagon receptors and cAMP formed measured as described ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K14/575C07K14/605A61K38/22A61K38/26A61K45/06A61P3/10A61P5/50A61P9/12A61P3/06A61P9/10A61P9/00
CPCA61K45/06C07K14/57563C07K14/605A61K38/00A61K38/26A61P3/04A61P3/06A61P5/50A61P9/00A61P9/10A61P9/12A61P3/10A61K38/2271A61K38/28A61K2300/00
Inventor M·博萨尔特R·埃尔弗特A·艾弗斯T·哈克S·斯坦格林M·瓦格纳K·洛伦茨
Owner SANOFI SA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap